Research: ‘So lucky’ to be alive after melanoma game-charger

09 Feb 2021 - Research

A new study published today in the peer-reviewed medical journal Nature Medicine has shown that a short course of immunotherapy drug treatment before surgery is effective in preventing the deadly spread of the disease in melanoma patients who are at high risk of the cancer recurring. The study suggests immunotherapy may work more effectively in patients with stage three melanoma when given before rather than after surgery because the bulky tumour can provoke an immune response. It found three quarters of patients in the trial responded well to dual immunotherapy given before surgery and only 3 per cent had their tumours return after, suggesting 97 per cent could be cured.

Sydney Morning Herald; 09/02/2021; Page 17